NewAmsterdam Pharma Company
NAMS
#3678
Rank
$3.44 B
Marketcap
$29.98
Share price
-4.06%
Change (1 day)
33.78%
Change (1 year)

Operating Margin for NewAmsterdam Pharma Company (NAMS)

Operating Margin as of March 2026 (TTM): -1,002.90%

According to NewAmsterdam Pharma Company's latest financial reports and stock price the company's current Operating Margin is -1,002.90%. At the end of 2025 the company had an Operating Margin of -905.74%.

Operating Margin history for NewAmsterdam Pharma Company from 2023 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2025-905.74%70.81%
2024-530.25%-57.77%
2023-1,255.57%5596.72%
2022-22.04%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.